Feb 23 (Reuters) - Pharmaceutical companies last year launched new U.S. drugs at prices 35% higher than in 2022, reflecting in part the industry's embrace of expensive therapies for rare diseases like ...

President Joe Biden and former President Donald Trump have seemingly found one issue they can agree on: Drug costs are too high. Each is crediting himself with price-busting policy successes that ...

Drugmaker price hikes that have occurred in tandem with ongoing drug shortages have not only created headaches for both hospitals and providers — but also jeopardized patient access to care, according ...

Justine Mallatt ([email protected]), Bureau of Economic Analysis, Washington, D.C. Abe Dunn, Bureau of Economic Analysis. Lasanthi Fernando, Bureau of Economic Analysis. A 2023 KFF survey reported ...